»
«
Offline Showroom in USA
Post Offer Free
MOSINTER GROUP LIMITED
MOSINTER GROUP LIMITED

China Growth hormone releasing peptide CAS 87616-84-0 GROWTH HORMONE RELEASING PEPTIDE-6 manufacturer

5th

Gold Index: 89140

You are here: home  > New products  > Growth hormone releasing peptide CAS 87616-84-0 GROWTH HORMONE RELEASING PEPTIDE-6

Growth hormone releasing peptide CAS 87616-84-0 GROWTH HORMONE RELEASING PEPTIDE-6 

Payment Terms: T/T,L/C,WU 
Place of Origin: Zhejiang, China (Mainland) 
inquire skype
Add to My Favorites
HiSupplier Escrow
Share |

Product Detail

Model No.: MOS 33
Production Capacity: 200KG/MONTH
Delivery Date: within 7 days
CAS: 87616-84-0
Molecular Weight: 873.01
Brand: MOSINTER
Synonyms 2: GROWTH HORMONE RELEASING PE...
Means of Transport: Ocean,Land,Air
Packing: As per request of clients
Name: Growth hormone releasing pe...
Molecular Formula: C46H56N12O6
Product Categories: Peptide;Peptides
Synonyms 1: (D-TRP7,ALA8,D-PHE10)-ALPHA...
storage temp: -20°C

Polypeptide; Peptides; Pharmaceutical raw materials; Peptide; Polypeptide intermediates

Growth hormone releasing peptide CAS 87616-84-0 GROWTH HORMONE RELEASING PEPTIDE-6

Polypeptide; Peptides; Pharmaceutical raw materials; Peptide; Polypeptide intermediates


GHRH is released from neurosecretory nerve terminals of these arcuate neurons, and is carried by the hypothalamo-hypophyseal portal system to the anterior pituitary gland, where it stimulatesgrowth hormone (GH) secretion by stimulating the growth hormone-releasing hormone receptor. GHRH is released in a pulsatile manner, stimulating similar pulsatile release of GH. In addition, GHRH also promotes slow-wave sleep directly.Growth hormone is required for normal postnatal growth, bone growth, regulatory effects on protein, carbohydrate, and lipid metabolism.


GHRH stimulates GH production and release by binding to the GHRH Receptor (GHRHR) on cells in the anterior pituitary.


GHRH expression has been demonstrated in peripheral cells and tissues outside its main site in the hypothalamus, for example, in the pancreas, epithelial mucosa of the gastrointestinal tract and, pathologically, in tumour cells.


The GHRHR is a member of the secretin family of G protein-coupled receptors, and is located on chromosome 7. This protein is transmembranous with seven folds, and its molecular weight is approximately 44 kD.


GHRH binding to GHRHR results in increased GH production mainly by the cAMP-dependent pathway,but also by the phospholipase C pathway (IP3/DAG pathway), and other minor pathways.

The cAMP-dependent pathway is initiated by the binding of GHRH to its receptor, causing receptor conformation that activates Gs alpha subunit of the closely associated G-Protein complex on the intracellular side. This results in stimulation of membrane-bound adenylyl cyclase and increased intracellular cyclic adenosine monophosphate (cAMP). cAMP binds to and activates the regulatory subunits of protein kinase A (PKA), allowing the free catalytic subunits to translocate to the nucleus and phosphorylate the transcription factor cAMP response element-binding protein (CREB). Phosphorylated CREB, together with its coactivators, p300 and CREB-binding protein (CBP) enhances the transcription of GH by binding to CREs cAMP-response elements in the promoter region of the GH gene. It also increases transcription of the GHRHR gene, providing positive feedback.

In the phospholipase C pathway, GHRH stimulates phospholipase C (PLC) through the βγ-complex of heterotrimeric G-proteins. PLC activation produces both diacylglycerol (DAG) and inositol triphosphate (IP3), the latter leading to release of intracellular Ca2+ from the endoplasmic reticulum, increasing cytosolic Ca2+ concentration, resulting in vesicle fusion and release of secretory vesicles containing premade growth hormone.

Some Ca2+ influx is also a direct action of cAMP, which is distinct from the usual cAMP-dependent pathway of activating protein kinase A.

Activation of GHRHRs by GHRH also conveys opening of Na+ channels by phosphatidylinositol 4,5-bisphosphate, causing cell depolarization. The resultant change in the intracellular voltage opens avoltage-dependent calcium channel, resulting in vesicle fusion and release of GH.



bigPhoto
skype Mr. Fedor

Tel: +86-574-89212210
Fax: +86-574-89212215
Mobile: 86- 189 8930 5995
Contact to this supplier

Didn't find what you're looking for? Post Buying Lead or contact HiSupplier Customer Service Center  for help!

Related Search

Find more related products in following catalogs on Hisupplier.com

Other products from this supplier

Company Info

MOSINTER GROUP LIMITED [China (Mainland)]

sgs ico Offline Showroom in USA

Business Type:Manufacturer, Trading Company
City: Ningbo
Province/State: Zhejiang
Country/Region: China (Mainland)

Follow Us: Follow us on facebook Follow us on linkedin

Fedor:   skype

You May Like: